Schedule 13G ownership disclosure

Zevra Therapeutics Inc

Security class unavailable · CUSIP: 488445206

Event date: 2021-04-09

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,056,500
Percent of class
7.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001683168-21-001468
Form type
SC 13G
Filer
Braun Samuel J
CIK
CIK 1857651
Filed
Apr 19, 2021
Reporting period
Apr 09, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub